Dentsply Sirona's stock surged 6.89% in after-hours trading following the release of its fourth quarter and full year 2025 financial results.

The dental products maker reported Q4 2025 net sales of $961 million, representing a 6.2% increase, while full-year revenue reached $3.68 billion, beating analyst estimates of $3.645 billion. However, the company reported a significant miss on adjusted earnings per share, with FY2025 adjusted EPS at $0.27 compared to estimates of $1.60, driven by $144 million in goodwill and intangible impairments.

Investors appeared to focus on positive developments including a restructuring plan expected to generate approximately $120 million in annualized cost savings, with savings to be redirected toward growth initiatives. The company also announced the elimination of its quarterly cash dividend to redeploy capital toward debt retirement and share repurchases. For FY2026, Dentsply Sirona provided guidance for net sales of $3.5-$3.6 billion and adjusted EPS of $1.40-$1.50.